Pharma Industry News 30 December 2025

Revolution Medicines (RVMD) stock slips in premarket as AbbVie denies takeover talks, deal buzz lingers

New York, Jan 8, 2026, 05:22 EST — Premarket Shares of Revolution Medicines fell 9.8% to $92.60 in premarket trading on Thursday, pulling back after a sharp, rumor-driven run-up in the prior session. Investing The whipsaw started after the Wall

8 January 2026

Investment Trends·Pharma Industry·Stock Market News

Crinetics (CRNX) shares jump as $350 million stock sale clears and early PALSONIFY revenue hits

New York, Jan 7, 2026, 11:04 EST — Regular session Shares of Crinetics Pharmaceuticals rose about 16% to $53.40 on Wednesday, after the biotech priced a $350 million stock offering and detailed early U.S. launch metrics for its newly approved

7 January 2026

Biotech Stocks·Earnings Reports·Investment Analysis·Market News·Pharma Industry

Ventyx Biosciences stock jumps premarket as Eli Lilly buyout talks fuel takeover buzz

New York, Jan 7, 2026, 05:03 EST — Premarket Ventyx Biosciences shares jumped about 66% before the bell on Wednesday after a report that Eli Lilly is in advanced talks to buy the biotech company for more than $1 billion.

7 January 2026

Biotech News·Investment·Mergers and Acquisitions·Pharma Industry·Stock Market

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says

Mumbai, Jan 7, 2026, 12:33 IST Shares of Cipla were down 4.6% at 1,460.2 rupees by midday on Wednesday after the U.S. Food and Drug Administration published inspection observations for Pharmathen International S.A., a contract manufacturer linked to the Indian

7 January 2026

Company Analysis·Investment News·Pharma Industry·Stock Market

Wave Life Sciences stock jumps 17% as obesity gene-silencing race heats up

New York, January 6, 2026, 11:28 EST — Regular session Wave Life Sciences Ltd shares (WVE.O) jumped about 17% on Tuesday, extending sharp swings in the obesity drug trade as investors sized up the next set of clinical readouts. The

6 January 2026

Biotechnology·Pharma Industry·Stock Market

NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

New York, Jan 5, 2026, 15:21 EST — Regular session Shares of NewAmsterdam Pharma Company N.V. fell about 5% to $33.42 in afternoon trading on Monday. The Nasdaq-listed stock hit an intraday low of $32.68 after opening at $35.15. The

5 January 2026

Insider Trading·Investment Tips·Pharma Industry·Stock Market

Eli Lilly stock: What to watch before Monday as JPM Healthcare and earnings near

NEW YORK, Jan 4, 2026, 17:22 ET — Market closed Eli Lilly shares rose 0.5% to $1,080.36 at Friday’s close, leaving the stock near the top of its recent range as U.S. markets remained shut over the weekend. Lilly Investor

4 January 2026

Earnings Reports·Financial News·Investing·Pharma Industry·Stock Market

Wave Life Sciences stock tumbles 8.5% in first 2026 session as traders refocus on next WVE-007 readout

NEW YORK, January 2, 2026, 14:13 ET — Regular session Wave Life Sciences Ltd shares slid on Friday, giving back part of last month’s obesity-driven run as the biotech sector wobbled in the first U.S. session of 2026. The stock

2 January 2026

Biotechnology·Company Earnings·Investment News·Pharma Industry·Stock Market

Cytokinetics (CYTK) stock closes up 3.5% into year-end as Myqorzo launch nears, insider sale disclosed

NEW YORK, January 1, 2026, 21:17 ET — Market closed Cytokinetics, Incorporated shares ended Wednesday up 3.5% at $63.54, the final U.S. trading session of 2025, after markets closed Thursday for the New Year’s Day holiday. The stock has traded

2 January 2026

Biotechnology·Investments·Market News·Pharma Industry·Stocks

Merck (MRK) stock slips into 2026 as New Year holiday shuts U.S. markets — what investors watch next

NEW YORK, January 1, 2026, 14:30 ET — Market closed Merck & Co.’s stock ended the year’s final trading session lower and was little changed in after-hours trading — the session after the 4 p.m. close — with U.S. markets

1 January 2026

Financial News·Investing·Market Trends·Pharma Industry·Stock Market

Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook

NEW YORK, December 30, 2025, 13:50 ET — Regular session Pfizer Inc (NYSE:PFE) shares were up about 0.1% at $25.03 in afternoon trading on Tuesday, after moving between $24.92 and $25.10. TD Cowen reiterated its Hold rating and kept a

30 December 2025

Financial Outlook·Investment News·Pfizer·Pharma Industry·Stock Market

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

NEW YORK, December 30, 2025, 01:49 ET — Market closed SELLAS Life Sciences Group Inc (SLS) shares jumped 16.7% on Monday to close at $3.35 after the company updated investors on the timing of a late-stage acute myeloid leukemia (AML)

30 December 2025

Biotechnology·Clinical Trials·Investment News·Pharma Industry·Stock Market

Pharma Industry News 30 December 2025 - 8 January 2026